Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients

Table 3

Median and 5-year survival results according to the factors demonstrating independent significance in multivariate analysis.

Survival	()	()	value	N0 ()	N1-2 ()	value	()	()	value
OS
Median (mo.)	21.3	12.2	0.016	18.4	11.6	0.006	12.8	19.2	0.001
5-year (%)	28.7	6.3		26.1	10.4		8.3	30.3
PFS
Median (mo.)	13.4	5.6	0.022	12.2	6.3	0.003	6.8	11.3	0.005
5-year (%)	18.9	4.1		20.2	4.9		5.0	19.6

Abbreviations: CA 19-9: cancer antigen 19-9; N0-2; nodal stage 0-2; AAPR: albumin-to-alkaline phosphatase ratio; OS: overall survival; PFS: progression-free survival.